Cardiac resynchronisation therapy: current indications, management and basic troubleshooting

Rao, Praveen; Faddis, Mitchell N.

doi:10.1136/heartjnl-2016-310656

Cited by 6 publications

(2 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cardiac resynchronisation therapy (CRT) is an important adjunct to optimal medical therapy (OMT) for reducing morbidity and mortality in symptomatic heart failure patients with significant conduction delay [1] , [2] . A complex milieu of electromechanical factors including myocardial substrate composition, CRT lead positioning, medical therapy and underlying patient characteristics are known to modulate the level of response to CRT [3] . Importantly, only two thirds of patients meeting guideline criteria for CRT implantation garner optimal benefits from this device therapy [4] .…”

Section: Introductionmentioning

confidence: 99%

Global longitudinal strain as a prognostic marker in cardiac resynchronisation therapy: A systematic review

Appadurai

D’Elia

Mew

et al. 2021

IJC Heart & Vasculature

View full text Add to dashboard Cite

Highlights Left ventricular global longitudinal strain (LV GLS) is a sensitive parameter that correlates with myocardial scar burden and fibrosis with potential value in CRT candidates. First systematic review evaluating the existing evidence for the prognostic value of LV GLS in patients undergoing CRT implantation. Despite significantly abnormal baseline GLS at CRT implantation, there is still a significant association between incrementally worse LV GLS at CRT implantation and prognostic outcomes on long-term follow-up.

show abstract

Section: Introductionmentioning

confidence: 99%

Global longitudinal strain as a prognostic marker in cardiac resynchronisation therapy: A systematic review

Appadurai

D’Elia

Mew

et al. 2021

IJC Heart & Vasculature

View full text Add to dashboard Cite

show abstract

“…The Education in Heart article9 in this issue discusses cardiac resynchronisation therapy for management of heart failure with reduced ejection fraction. The pathophysiologic rationale, patient selection, and procedural technique are summarised concisely in this article.…”

mentioning

confidence: 99%

Heartbeat: Healthcare approaches to reducing adverse outcomes in patients with atrial fibrillation

Otto¹

2017

Heart

View full text Add to dashboard Cite

Safety and Effectiveness of Medical Device Therapy

Zusterzeel

2018

Advances in Experimental Medicine and Biology

View full text Add to dashboard Cite

When enough females and males are enrolled in clinical trials, much more relevant information is available on potential sex differences in device safety and effectiveness. Unfortunately, females have largely been underrepresented in clinical studies of cardiac medical device therapies for heart failure. In this chapter, sex differences in heart failure characteristics and cardiac electrophysiology and their influence on the safety, effectiveness, and application of implantable cardioverter defibrillators (ICDs), subcutaneous ICDs (S-ICDs), and cardiac resynchronization therapy (CRT) will be discussed. In this way, the research community will hopefully become more appreciative of the potential differences in device effects between females and males.

show abstract

Cardiac resynchronisation therapy: current indications, management and basic troubleshooting

Cited by 6 publications

References 50 publications

Global longitudinal strain as a prognostic marker in cardiac resynchronisation therapy: A systematic review

Global longitudinal strain as a prognostic marker in cardiac resynchronisation therapy: A systematic review

Heartbeat: Healthcare approaches to reducing adverse outcomes in patients with atrial fibrillation

Safety and Effectiveness of Medical Device Therapy

Contact Info

Product

Resources

About